Picture of Taisho Pharmaceutical Holdings Co logo

4581 — Taisho Pharmaceutical Holdings Co News Story

0.000.00%
jp flag iconLast trade - 00:00
HealthcareBalancedLarge CapHigh Flyer

Table: Taisho Pharmaceutical HD - 6-MTH group results

Nov 10 (Reuters)- 
             Taisho Pharmaceutical Holdings Co Ltd 
             CONSOLIDATED FINANCIAL HIGHLIGHTS 
     (in billions of yen unless specified)                
                   6 months ended      6 months ended       Year to 
                  Sep 30, 2022        Sep 30, 2021     Mar 31, 2023 
                     LATEST             YEAR-AGO          LATEST    
                     RESULTS             RESULTS         FORECAST   
  Sales              144.52              130.16           280.50    
                   (+11.0 pct)         (-10.8 pct)      (+4.6 pct)  
  Operating           12.21                2.31            16.00    
                  (+427.6 pct)         (-85.8 pct)      (+48.9 pct) 
  Recurring           17.34                4.22            20.00    
                  (+310.7 pct)         (-77.6 pct)      (+8.6 pct)  
  Net                 10.88                2.91            12.00    
                  (+274.0 pct)         (-74.3 pct)      (-8.6 pct)  
  EPS              132.68 yen           35.95 yen       146.26 yen  
  EPS Diluted      132.52 yen           35.90 yen                   
  Ann Div                              100.00 yen       100.00 yen  
  -Q2 div           50.00 yen           50.00 yen                   
  -Q4 div                               50.00 yen        50.00 yen  
  
  NOTE - Taisho Pharmaceutical Holdings Co Ltd. 
  To see Company Overview page, click reuters://REALTIME/verb=CompanyData/ric=4581.T

Recent news on Taisho Pharmaceutical Holdings Co

See all news